Cosmo Pharmaceuticals N.V. (CMOPF)
USD 66.93
(0.0%)
USD 66.93
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 33.62 Million | 33.63 Million | 13.38 Million | 11.4 Million | -21.4 Million | -8.63 Million |
| Net Income | 1.53 Million | 18.69 Million | 25.67 Million | -9.56 Million | -28.04 Million | -21.08 Million |
| Depreciation & Amortization | 14.26 Million | 15.04 Million | 8.72 Million | 7.3 Million | 6.61 Million | 5.25 Million |
| Deferred income taxes | - | -46.77 Million | -21.65 Million | -31.91 Million | -31.29 Million | - |
| Stock-based compensation | 3.82 Million | 2.07 Million | 1.45 Million | 8.99 Million | 10.08 Million | 9.58 Million |
| Change in working capital | 946 Thousand | -14.45 Million | -6 Million | -6.21 Million | -10.36 Million | -4.04 Million |
| Other non-cash items | 13.2 Million | 59.04 Million | 5.18 Million | 42.81 Million | 31.6 Million | 24.96 Million |
| Investing Cash Flow | 42.3 Million | -481.94 Thousand | 25.81 Million | 90.33 Million | -59.61 Million | -87.34 Million |
| Investments in PPE | -15.31 Million | -7.93 Million | -10.07 Million | -9.78 Million | -19.88 Million | -11.32 Million |
| Acquisitions | -2.2 Million | - | 27.64 Million | -4.12 Million | -3.44 Million | 32.79 Thousand |
| Investment purchases | -60.95 Million | -58.66 Million | -1.18 Million | -29.21 Million | -103.18 Million | -206.25 Million |
| Sales/Maturities of investments | 117.73 Million | 38.98 Million | 9.16 Million | 159.31 Million | 78.3 Million | 130.2 Million |
| Other Investing Activities | 50.39 Million | 27.13 Million | 268.88 Thousand | -25.85 Million | -11.39 Million | -79 Thousand |
| Financing Cash Flow | -211.26 Million | -45.32 Million | -27.09 Million | -9.08 Million | -36.13 Million | 169.11 Million |
| Debt repayment | -176.02 Million | -994.27 Thousand | -3.7 Million | -2.16 Million | -7.03 Million | -190.6 Million |
| Dividends payments | -19.49 Million | -16.94 Million | - | - | - | - |
| Common Stock Repurchased | -12.47 Million | -27.68 Million | -23.38 Million | -13.28 Million | -29.09 Million | -21.49 Million |
| Common Stock Issuance | 687 Thousand | 293.07 Thousand | 761 Thousand | 6.35 Million | - | - |
| Other Financing Activities | -2 Million | -1.00 | -503 Thousand | -2.89 | -1.00 | -2.84 Million |
| Accounts receivables | 8.25 Million | -15.37 Million | 3.9 Million | -9.58 Million | -4.26 Million | 735.51 Thousand |
| Accounts payables | 1.04 Million | -1 Million | 551.97 Thousand | 739.59 Thousand | -1.19 Million | -3.13 Million |
| Inventory | -2.7 Million | 1.75 Million | -7.19 Million | 527.76 Thousand | -2.53 Million | -815.16 Thousand |
| Other working capital | -5.08 Million | 168.24 Thousand | -3.26 Million | 2.09 Million | -2.38 Million | -833.9 Thousand |
| Cash at beginning of period | 185.82 Million | 225.51 Million | 227.5 Million | 123.9 Million | 240.84 Million | 174.04 Million |
| Cash at end of period | 50.27 Million | 198.42 Million | 225.51 Million | 227.5 Million | 123.9 Million | 240.84 Million |
| Capital Expenditure | -15.31 Million | -7.93 Million | -10.07 Million | -9.78 Million | -19.88 Million | -11.32 Million |
| Effect of forex changes on cash | -210 Thousand | -1.51 Million | 2.4 Million | -997 Thousand | 1.69 Million | 3.29 Million |
| Net cash flow / Change in cash | -135.55 Million | -27.08 Million | -1.99 Million | 103.59 Million | -116.93 Million | 66.8 Million |
| Free Cash Flow | 18.31 Million | 25.69 Million | 3.3 Million | 1.62 Million | -41.29 Million | -19.96 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 81.27 Million | 1.53 Million | -7.29 Million | 1.63 Million | 18.69 Million | 9.89 Million |
| Depreciation & Amortization | 7.79 Million | 14.26 Million | 8.36 Million | 7.6 Million | 15.04 Million | 7.45 Million |
| Deferred income taxes | - | - | - | - | -46.77 Million | - |
| Stock-based compensation | - | 3.82 Million | - | - | 2.07 Million | - |
| Change in working capital | 4.75 Million | 946 Thousand | 370.14 Thousand | 663.64 Thousand | -14.45 Million | -9.99 Million |
| Other non-cash items | 18.74 Million | 13.2 Million | 32.74 Million | 15.33 Million | 59.04 Million | 37.48 Million |
| Investing Cash Flow | -95.74 Million | 42.3 Million | 113.23 Million | -62.11 Million | -481.94 Thousand | -36.9 Million |
| Investments in PPE | -12.34 Million | -15.31 Million | -8.75 Million | -8.14 Million | -7.93 Million | -4.9 Million |
| Acquisitions | - | -2.2 Million | 1.17 Million | -1.1 Million | - | 0.86 |
| Investment purchases | -83.39 Million | -60.95 Million | 5.18 Million | -70.05 Million | -58.66 Million | -56.32 Million |
| Sales/Maturities of investments | - | 117.73 Million | 115.63 Million | 17.18 Million | 38.98 Million | -2.12 Million |
| Other Investing Activities | - | 50.39 Million | - | -1.00 | 27.13 Million | 26.44 Million |
| Financing Cash Flow | -5.26 Million | -211.26 Million | -207.9 Million | -25.77 Million | -45.32 Million | -11.5 Million |
| Debt repayment | - | -176.02 Million | - | - | -994.27 Thousand | -0.81 |
| Dividends payments | - | -19.49 Million | -4.38 Million | -13.94 Million | -16.94 Million | -3.45 Million |
| Common Stock Repurchased | -2.61 Million | -12.47 Million | -1.28 Million | -12.13 Million | -27.68 Million | -7.36 Million |
| Common Stock Issuance | 2.15 Million | 687 Thousand | 484.08 Thousand | 279.54 Thousand | 293.07 Thousand | 285.61 Thousand |
| Other Financing Activities | -4.81 Million | -2 Million | -2.5 Million | 22.01 Thousand | -1.00 | -968.97 Thousand |
| Accounts receivables | 5 Million | 8.25 Million | 1.54 Million | 6.19 Million | -15.37 Million | -13.78 Million |
| Accounts payables | 3.33 Million | 1.04 Million | 663 Thousand | 343.37 Thousand | -1 Million | 565.9 Thousand |
| Inventory | 316.59 Thousand | -2.7 Million | -784.9 Thousand | -2.14 Million | 1.75 Million | 3.81 Million |
| Other working capital | -3.89 Million | -5.08 Million | -2.1 Million | -3.72 Million | 168.24 Thousand | -290.12 Thousand |
| Cash at beginning of period | 55.51 Million | 185.82 Million | 129.39 Million | 198.42 Million | 225.51 Million | 228.21 Million |
| Cash at end of period | 58.44 Million | 50.27 Million | 55.51 Million | 129.39 Million | 198.42 Million | 198.42 Million |
| Capital Expenditure | -12.34 Million | -15.31 Million | -8.75 Million | -8.14 Million | -7.93 Million | -4.9 Million |
| Effect of forex changes on cash | - | -210 Thousand | - | -0.19 | -1.51 Million | 0.03 |
| Net cash flow / Change in cash | 2.92 Million | -135.55 Million | -73.87 Million | -69.02 Million | -27.08 Million | -29.79 Million |
| Free Cash Flow | 93.28 Million | 18.31 Million | 10.12 Million | 6.26 Million | 25.69 Million | 15.62 Million |
007280
084010
EIC
IVITF
002317
AGGI